Another finding in line with our results is the fact that the cellular cytotoxicity of temozolomide—a drug used for treatment of gliomas—has been at least partially attributed to its inhibitory effects on NF-κB [63]. The gene discussed is NFKB1; the disease is central nervous system cancer.